Evaluation of the Influence of Risk Factors on the Time of Onset of Ulcers, Rest Pain, and New Gangrene Post-Angioplasty in Patients with Chronic Limb Threatening Ischemia (CLTI) at Dr. Cipto Mangunkusumo General Hospital

Authors

  • Haikal Effendi Universitas Indonesia
  • Raden Suhartono Universitas Indonesia
  • Aria Kekalih Universitas Indonesia

DOI:

https://doi.org/10.55324/ijoms.v4i11.1178

Keywords:

Chronic Limb Threatening Ischemia, angioplasty, diabetes mellitus, hypertension, chronic kidney disease, rest pain, ulcers, gangrene, risk factors

Abstract

Chronic Limb Threatening Ischemia (CLTI) represents the end stage of peripheral arterial disease, characterized by rest pain, ulcers, and gangrene. This study aims to evaluate the influence of metabolic risk factors—namely diabetes mellitus (DM), chronic kidney disease (CKD), and hypertension—on the timing of new symptom onset. This study employed a retrospective observational design involving CLTI patients who underwent successful angioplasty at RSUPN Dr. Cipto Mangunkusumo. Clinical data and the onset time of symptoms were collected and analyzed using univariate, bivariate, and multivariate logistic regression analyses. The study revealed a high prevalence of diabetes mellitus (89.3%, with 56% uncontrolled), hypertension (77.3%, with 41.3% uncontrolled), and chronic kidney disease (32%). Post-angioplasty symptoms included gangrene (33.3%), rest pain (24%), combined rest pain and gangrene (24%), and ulcers (18.7%), with a mean onset time of 80 ± 105 days. Uncontrolled diabetes mellitus (p=0.001; mean 39.46 days), hypertension (p=0.006; mean 54.81 days), and chronic kidney disease (p=0.001; mean 29.58 days) were significantly associated with accelerated symptom onset. Multivariate regression analysis identified hypertension as the strongest predictor (p=0.021; B=59.234; ?=0.273), followed by DM (p=0.027; B=40.693; ?=0.249) and CKD (p=0.036; B=30.234; ?=0.226), collectively explaining 53.9% of the variation in onset time. Uncontrolled DM was associated with increased incidence of ulcers and gangrene; hypertension with combined rest pain and gangrene; while CKD was more frequently associated with rest pain. These findings highlight the importance of aggressive risk factor management and structured post-angioplasty monitoring to delay symptom onset and reduce complications.

References

Aboyans, V., Ricco, J. B., Bartelink, M. E. L., Björck, M., Brodmann, M., Cohnert, T., Collet, J. P., Czerny, M., De Carlo, M., Debus, S., Espinola-Klein, C., Kahan, T., Kownator, S., Mazzolai, L., Naylor, A. R., Roffi, M., Röther, J., Sprynger, M., Tendera, M., & ESC Scientific Document Group. (2018). 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). European Heart Journal, 39(9), 763–816. https://doi.org/10.1093/eurheartj/ehx095

Conte, M. S., Bradbury, A. W., Kolh, P., White, J. V., Dick, F., Fitridge, R., Mills, J. L., Ricco, J. B., Suresh, K. R., Murad, M. H., & GVG Writing Group. (2019). Global vascular guidelines on the management of chronic limb-threatening ischemia. Journal of Vascular Surgery, 69(6S), 3S–125S.e40. https://doi.org/10.1016/j.jvs.2019.02.016

Davies, M. G. (2019). Metabolic factors in peripheral arterial disease: Impact on outcomes. Seminars in Vascular Surgery, 32(1–2), 22–28. https://doi.org/10.1053/j.semvascsurg.2019.04.002

Fowkes, F. G. R., Rudan, D., Rudan, I., Aboyans, V., Denenberg, J. O., McDermott, M. M., Norman, P. E., Sampson, U. K. A., Williams, L. J., Mensah, G. A., & Criqui, M. H. (2013). Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: A systematic review and analysis. The Lancet, 382(9901), 1329–1340. https://doi.org/10.1016/S0140-6736(13)61249-0

Gerhard-Herman, M. D., Gornik, H. L., Barrett, C., Barshes, N. R., Corriere, M. A., Drachman, D. E., Fleisher, L. A., Fowkes, F. G. R., Hamburg, N. M., Kinlay, S., Lookstein, R., Misra, S., Mureebe, L., Olin, J. W., Patel, R. A. G., Regensteiner, J. G., Schanzer, A., Shishehbor, M. H., Stewart, K. J., ... Walsh, M. E. (2017). 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease. Circulation, 135(12), e726–e779. https://doi.org/10.1161/CIR.0000000000000471

Kementerian Kesehatan Republik Indonesia. (2018). Riset Kesehatan Dasar (Riskesdas) 2018. Badan Penelitian dan Pengembangan Kesehatan.

Krisdinarti, L., Dewi, F. S., & Santoso, A. (2020). Prevalence and risk factors of peripheral artery disease in Indonesia: A cross-sectional study. Indonesian Journal of Cardiology, 41(2), 89–95.

Laurent, S., Chatellier, G., Azizi, M., Calvet, D., Choukroun, G., Danchin, N., Pannier, B., Safar, M., & Plouin, P. F. (2020). Hypertension and peripheral artery disease: A dangerous liaison. Journal of Hypertension, 38(7), 1235–1243. https://doi.org/10.1097/HJH.0000000000002375

Mills, J. L., Conte, M. S., Armstrong, D. G., Pomposelli, F. B., Schanzer, A., Sidawy, A. N., & Andros, G. (2018). The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk stratification based on Wound, Ischemia, and foot Infection (WIfI). Journal of Vascular Surgery, 67(1), 220–230. https://doi.org/10.1016/j.jvs.2017.08.098

Mills, J. L., Sr., Conte, M. S., Armstrong, D. G., Pomposelli, F. B., Schanzer, A., Sidawy, A. N., & Andros, G. (2014). The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk stratification based on wound, ischemia, and foot infection (WIfI). Journal of Vascular Surgery, 59(1), 220–234.e2. https://doi.org/10.1016/j.jvs.2013.08.003

Norgren, L., Hiatt, W. R., Dormandy, J. A., Nehler, M. R., Harris, K. A., & Fowkes, F. G. R. (2007). Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Journal of Vascular Surgery, 45(Supplement S), S5–S67. https://doi.org/10.1016/j.jvs.2006.12.037

Ohtake, T., Nakamura, Y., Shindo, M., Watanabe, H., & Inoue, Y. (2022). Impact of chronic kidney disease on outcomes of peripheral artery disease interventions. Journal of Vascular Surgery, 75(2), 573–581. https://doi.org/10.1016/j.jvs.2021.08.082

Prompers, L., Huijberts, M., Apelqvist, J., Jude, E., Piaggesi, A., Bakker, K., & Van Acker, K. (2021). High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Diabetologia, 64(5), 1043–1052. https://doi.org/10.1007/s00125-021-05396-5

RSUPN Dr. Cipto Mangunkusumo. (2023). Laporan Tahunan Divisi Bedah Vaskular RSUPN Dr. Cipto Mangunkusumo 2022. RSCM.

Santosa, F., Suharjono, H., & Intan, R. E. (2021). Outcomes of chronic limb-threatening ischemia in Indonesia: A single-center experience. Indonesian Journal of Vascular Surgery, 3(1), 12–18.

Santosa, M. A., & Suroto, H. F. M. (2021). Peripheral arterial disease in Southeast Asia: Prevalence and outcomes. International Journal of Surgery Open, 35, 100395. https://doi.org/10.1016/j.ijso.2021.100395

Selvin, E., Erlinger, T. P., & Brancati, F. L. (2022). Diabetes and the risk of peripheral artery disease: A prospective cohort study. Diabetes Care, 45(4), 897–904. https://doi.org/10.2337/dc21-1678

Downloads

Published

2025-08-14